1 in 350: What the Sickle Cell Birth Number for Black Newborns Actually Means
Deep-research Numbers article on sickle cell disease, explaining one disparity statistic with its definition, numerator, denominator, and limits. In the CDC Sickle Cell Data Collection analysis by Kayle et al. (MMWR 2024;73(12):248-254; PMID 38547025), laboratory-confirmed newborn screening records from 11 states during 2016-2020 (3,305 newborns with confirmed SCD among 6,846,827 live births) measured a birth prevalence of 28.54 per 10,000 (one in every 350) non-Hispanic Black newborns (2,970 cases among 1,040,778 births), versus 4.83 per 10,000 (one in 2,070) overall; 67% of mothers lived in counties with high or very high social vulnerability (89% on the minority-status theme; 64% on housing and transportation). The article prints the report's own numerator/denominator ethnicity caveat, the state spread (19.30 to 32.66 per 10,000), the older one-in-365 estimate based on 2007 data, and the life-expectancy context (52.6 years in a 94,616-person publicly insured cohort, Jiao et al. 2023, PMID 36929166). Supplement studies (SCOT DHA trial, n=67, crisis endpoint not significant; folic acid crossover, n=31) are used only as a scale check. No supplement claim, recommendation, or product is made; the mandatory sickle cell honesty box is included. Evidence grade: STRONG. Educational article from the Buddha Ayurvedic School of Medicine: https://buddha.hospital
Authors
- Ajarn Shaman Shu
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-20
- DOI
- https://doi.org/10.5281/zenodo.24399224
- Primary Topic
- Hemoglobinopathies and Related Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00